Evidence map

TrialAging2021

Anserine, HClO-scavenger, protected against cognitive decline in individuals with mild cognitive impairment.

Nobutaka Masuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33472172